Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market Research Report – Segmented By Type (molecular diagnostics, immunoassays, biosensors, others) and by End-User (hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, research and academic institutes, homecare settings); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Point of Care Testing for Vancomycin-Resistant Enterococcus Market Size (2024 – 2030)
The Global Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) Market was valued at approximately USD 0.8 billion in 2023 and is projected to grow at a CAGR of 9.5% from 2024 to 2030. By 2030, the market is expected to reach around USD 1.51 billion.
This market is expanding significantly due to the increasing prevalence of hospital-acquired infections (HAIs) and the growing emphasis on combating antimicrobial resistance (AMR). POCT for VRE is crucial in facilitating timely diagnosis and treatment, thereby improving patient outcomes and infection control measures in healthcare settings. With advancements in diagnostic technologies and heightened awareness of VRE's impact, the demand for these rapid testing solutions is on the rise.
Key Market Insights:
Technological advancements in POC testing, including molecular diagnostics and immunoassay techniques, have enhanced the accuracy and reliability of VRE detection, contributing to market expansion.
Government initiatives and healthcare policies aimed at controlling HAIs and antimicrobial resistance are playing a crucial role in promoting the adoption of VRE POC testing.
The integration of POC testing with electronic health records (EHR) is improving the efficiency of infection control measures, thereby boosting market growth.
Emerging markets in Asia-Pacific and Latin America are anticipated to provide lucrative opportunities due to the growing awareness of HAIs and the increasing adoption of POC testing technologies.
Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market Drivers:
Rising Incidence of Hospital-Acquired Infections (HAIs) is driving market growth: The increasing prevalence of HAIs, particularly those caused by multidrug-resistant organisms like VRE, is a major driver for the POC testing market. HAIs pose significant challenges in healthcare, leading to prolonged hospital stays, increased healthcare costs, and higher mortality rates. The need for rapid diagnosis and timely treatment of VRE infections is critical in controlling the spread of these infections within healthcare settings. POC testing provides an effective solution by enabling healthcare providers to quickly identify VRE and implement appropriate infection control measures, thereby reducing the incidence of HAIs.
Advancements in Point of Care Testing Technologies is driving market growth: Technological advancements in POC testing, particularly in molecular diagnostics and immunoassays, have significantly improved the accuracy, sensitivity, and specificity of VRE detection. Innovations such as PCR-based assays, lateral flow tests, and next-generation sequencing are enhancing the ability to detect VRE in real-time, even in resource-limited settings. These advancements are driving the adoption of POC testing for VRE, as they offer rapid and reliable results, which are crucial for effective patient management. The continuous development of new testing platforms and the integration of automation in POC devices are expected to further propel market growth.
Increasing Awareness and Government Initiatives on Antimicrobial Resistance (AMR) is driving market growth: The growing global concern over AMR has led to increased awareness and initiatives aimed at combating the spread of resistant organisms, including VRE. Governments and healthcare organizations worldwide are implementing policies and guidelines to promote the early detection and prevention of AMR through effective diagnostic tools. The emphasis on reducing the use of broad-spectrum antibiotics and improving infection control practices has highlighted the importance of rapid diagnostics like POC testing for VRE. These efforts are expected to drive the demand for POC testing solutions, as they play a pivotal role in supporting antimicrobial stewardship programs and reducing the burden of AMR.
Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market Challenges and Restraints:
Regulatory and Reimbursement Issues is restricting market growth: Stringent regulatory requirements and the need for extensive clinical validation can delay the approval and commercialization of new POC testing products. Additionally, reimbursement policies for POC testing vary widely, with some regions lacking adequate coverage, making it challenging for healthcare providers to justify the costs of implementing these technologies. The uncertainty surrounding regulatory approvals and reimbursement can hinder the market growth, as manufacturers may face challenges in bringing new products to market and achieving widespread adoption. Additionally, limited accessibility to these technologies in resource-poor settings remains a barrier to widespread adoption. Moreover, the lack of trained personnel to operate advanced POC devices and interpret results further exacerbates the challenge, particularly in low-income countries where healthcare infrastructure is already under strain.
Market Opportunities:
The increasing global focus on combating antimicrobial resistance (AMR) presents significant opportunities for the Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) market. As healthcare systems prioritize early detection and prevention of resistant infections, the demand for rapid diagnostic tools like POC testing is expected to rise. The development of novel POC testing technologies, including multiplex assays and portable molecular diagnostics, offers potential for more comprehensive and efficient detection of VRE and other resistant pathogens. Furthermore, the expansion of POC testing into emerging markets, coupled with the integration of these tests into antimicrobial stewardship programs, is likely to create new avenues for market growth. Strategic partnerships between diagnostic companies and healthcare providers to enhance the accessibility and affordability of POC testing in low-resource settings could further drive the market. Additionally, the increasing adoption of telemedicine and remote monitoring solutions is expected to boost the demand for POC testing, as these technologies enable decentralized testing and immediate decision-making in various healthcare environments.
POINT OF CARE TESTING FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS MARKET REPORT COVERAGE:
REPORT METRIC
DETAILS
Market Size Available
2023 - 2030
Base Year
2023
Forecast Period
2024 - 2030
CAGR
9.5%
Segments Covered
By Type, End-User,and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Key Companies Profiled
Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Siemens Healthineers,. Quidel Corporation,. bioMérieux SA, Danaher Corporation, Bio-Rad Laboratories, Meridian Bioscience
Point of Care Testing for Vancomycin-Resistant EnterococcusMarket Segmentation: By Type
Molecular Diagnostics
Immunoassays
Biosensors
By Type, Molecular Diagnostics is the dominant segment. This is due to its high accuracy and sensitivity in detecting Vancomycin-Resistant Enterococcus (VRE), which is critical for effective infection management. Molecular diagnostics, particularly PCR-based assays, offer rapid and precise results, making them essential in clinical settings where timely decisions are crucial. This technology's ability to detect low levels of VRE in patient samples enhances its adoption and drives its dominance in the market.
Point of Care Testing for Vancomycin-Resistant EnterococcusMarket Segmentation: By End-User
Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Research and Academic Institutes
Homecare Settings
Hospitals and Clinics is the leading segment. Hospitals and clinics are the primary settings where rapid and accurate VRE testing is crucial for infection control and patient management. The high patient volume and the need for immediate results in these settings contribute to the significant demand for Point of Care Testing solutions, making it the most prominent application segment in the market.
Point of Care Testing for Vancomycin-Resistant EnterococcusMarket Segmentation: By Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
North America is the dominant region in the Global Point of Care Testing for Vancomycin-Resistant Enterococcus Market. This dominance is attributed to the region's advanced healthcare infrastructure, high adoption rates of cutting-edge diagnostic technologies, and substantial investments in research and development. The U.S. and Canada have well-established healthcare systems and stringent infection control practices, which drive the demand for rapid and accurate diagnostic tools like POCT for VRE. Furthermore, robust government support, including funding for AMR research and healthcare initiatives, bolsters market growth. The presence of key market players and a high level of healthcare expenditure further reinforce North America's leading position in this market, setting benchmarks for innovation and implementation.
COVID-19 Impact Analysis on the Point of Care Testing for Vancomycin-Resistant Enterococcus Market:
The COVID-19 pandemic had a dual impact on the Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) market. Initially, the market faced significant disruptions due to supply chain interruptions, reduced healthcare spending, and the redirection of resources towards managing the pandemic. The focus on COVID-19 diagnostics led to a temporary decline in demand for POC testing for other infectious diseases, including VRE. However, as the pandemic progressed, the importance of infection control and the need for rapid diagnostic tools became more apparent. The pandemic underscored the necessity for effective diagnostic strategies to manage hospital-acquired infections (HAIs), including those caused by VRE. The increased awareness of the risks associated with HAIs and the emphasis on improving healthcare hygiene standards have subsequently driven the demand for VRE POC testing. Additionally, the accelerated adoption of telemedicine and remote monitoring during the pandemic has highlighted the role of POC testing in providing decentralized and immediate diagnostic solutions, contributing to the market's recovery and growth.
Latest Trends/Developments:
he Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) market is witnessing several key trends that are shaping its future. One of the prominent trends is the integration of artificial intelligence (AI) and machine learning (ML) into POC testing platforms. These technologies are being leveraged to enhance the accuracy, speed, and predictive capabilities of diagnostic tests. AI-driven algorithms are improving the interpretation of complex test results, enabling healthcare providers to make more informed decisions in real-time. Another significant trend is the shift towards miniaturized and portable POC testing devices, which offer greater convenience and ease of use in various healthcare settings, including remote and resource-limited areas. The growing focus on sustainability is also influencing the market, with companies exploring eco-friendly materials and manufacturing processes for POC testing devices. Additionally, there is an increasing emphasis on developing multiplex assays that can simultaneously detect multiple pathogens, including VRE, to provide comprehensive diagnostic solutions. The rise of personalized medicine is further driving the demand for POC testing, as these tests enable tailored treatment approaches based on rapid and precise diagnostics.
Key Players
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientific
Becton, Dickinson and Company (BD)
Siemens Healthineers
Quidel Corporation
bioMérieux SA
Danaher Corporation
Bio-Rad Laboratories
Meridian Bioscience
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Key Players:
AMS Osram
Cree
Hella
Hyundai Mobis
Koito
Luminus Devices
Magneti Marelli
Osram Licht AG
Stanley Electric
Valeo
Chapter 1. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources Chapter 2. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis Chapter 3. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis Chapter 4. Point of Care Testing for Vancomycin-Resistant Enterococcus Market - Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes Chapter 5. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities Chapter 6. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – By Type
6.1 Introduction/Key Findings
6.2 Molecular Diagnostics
6.3 Immunoassays
6.4 Biosensors
6.5 Y-O-Y Growth trend Analysis By Type
6.6 Absolute $ Opportunity Analysis By Type, 2024-2030 Chapter 7. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – By End-User
7.1 Introduction/Key Findings
7.2 Hospitals and Clinics
7.3 Diagnostic Laboratories
7.4 Ambulatory Surgical Centers
7.5 Research and Academic Institutes
7.6 Homecare Settings
7.7 Y-O-Y Growth trend Analysis By End-User
7.8 Absolute $ Opportunity Analysis By End-User, 2024-2030 Chapter 8. Point of Care Testing for Vancomycin-Resistant Enterococcus Market , By Geography – Market Size, Forecast, Trends & Insights
8.1 North America
8.1.1 By Country
8.1.1.1 U.S.A.
8.1.1.2 Canada
8.1.1.3 Mexico
8.1.2 By Type
8.1.3 By End-User
8.1.4 Countries & Segments - Market Attractiveness Analysis
8.2 Europe
8.2.1 By Country
8.2.1.1 U.K
8.2.1.2 Germany
8.2.1.3 France
8.2.1.4 Italy
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.2.2 By Type
8.2.3 By End-User
8.2.4 Countries & Segments - Market Attractiveness Analysis
8.3 Asia Pacific
8.3.1 By Country
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 South Korea
8.3.1.4 India
8.3.1.5 Australia & New Zealand
8.3.1.6 Rest of Asia-Pacific
8.3.2 By Type
8.3.3 By End-User
8.3.4 Countries & Segments - Market Attractiveness Analysis
8.4 South America
8.4.1 By Country
8.4.1.1 Brazil
8.4.1.2 Argentina
8.4.1.3 Colombia
8.4.1.4 Chile
8.4.1.5 Rest of South America
8.4.2 By Type
8.4.3 By End-User
8.4.4 Countries & Segments - Market Attractiveness Analysis
8.5 Middle East & Africa
8.5.1 By Country
8.5.1.1 United Arab Emirates (UAE)
8.5.1.2 Saudi Arabia
8.5.1.3 Qatar
8.5.1.4 Israel
8.5.1.5 South Africa
8.5.1.6 Nigeria
8.5.1.7 Kenya
8.5.1.8 Egypt
8.5.1.9 Rest of MEA
8.5.2 By Type
8.5.3 By End-User
8.5.4 Countries & Segments - Market Attractiveness Analysis Chapter 9. Point of Care Testing for Vancomycin-Resistant Enterococcus Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1 Abbott Laboratories
9.2 Roche Diagnostics
9.3 Thermo Fisher Scientific
9.4 Becton, Dickinson and Company (BD)
9.5 Siemens Healthineers
9.6 Quidel Corporation
9.7 bioMérieux SA
9.8 Danaher Corporation
9.9 Bio-Rad Laboratories
9.10 Meridian Bioscience
Fill out the form below and our team will get back to you shortly
FAQ's
The Global Point of Care Testing for Vancomycin-Resistant Enterococcus (VRE) Market was valued at approximately USD 0.8 billion in 2023 and is projected to grow at a CAGR of 9.5% from 2024 to 2030. By 2030, the market is expected to reach around USD 1.51 billion.
Major drivers include the rising incidence of hospital-acquired infections (HAIs), advancements in testing technologies, and increased awareness and government initiatives on antimicrobial resistance (AMR).
The market is segmented by product type (molecular diagnostics, immunoassays, biosensors, others) and by application (hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, research and academic institutes, homecare settings).
North America is the most dominant region due to advanced healthcare infrastructure, high adoption rates of new technologies, and significant market players in the region.
Key players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Siemens Healthineers, Quidel Corporation, bioMérieux SA, Danaher Corporation, Bio-Rad Laboratories, and Meridian Bioscience.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”